{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:37:55Z","timestamp":1753889875762,"version":"3.41.2"},"reference-count":15,"publisher":"Gobierno de Navarra","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"DOI":"10.23938\/assn.1006","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T07:50:01Z","timestamp":1660722601000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic clues in atypical hemolytic uremic syndrome: a case report"],"prefix":"10.23938","volume":"45","author":[{"given":"M.","family":"Luquin Irigoyen","sequence":"first","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos. Hospital Universitario de Navarra. Servicio Navarro de Salud-Osasunbidea. Pamplona. Espa\u00f1a.. maria.luquin.irigoyen@navarra.es"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Armendariz Brugos","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos. Hospital Universitario de Navarra. Servicio Navarro de Salud-Osasunbidea. Pamplona. Espa\u00f1a.. cristina.armendariz.brugos@navarra.es"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vallejo Ruiz","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos. Hospital Universitario de Navarra. Servicio Navarro de Salud-Osasunbidea. Pamplona. Espa\u00f1a.. miren.vallejo.ruiz@navarra.es"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10024","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. NORIS M, REMUZZI G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687. https:\/\/doi.org\/10.1056\/NEJMra0902814.","DOI":"10.1056\/NEJMra0902814"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. TIMMERMANS S, WERION A, SPAANDERMAN M, REUTELINGSPERGER C, DAMOISEAUX J, MORELLE J et al. The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives. Br J Haematol 2020; 190: 442-449. https:\/\/doi.org\/10.1111\/bjh.16626.","DOI":"10.1111\/bjh.16626"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. CAMPISTOL JM, ARIAS M, ARICETA G, BLASCO M, ESPINOSA L, ESPINOSA M et al. Actualizaci\u00f3n en s\u00edndrome hemol\u00edtico ur\u00e9mico at\u00edpico: diagn\u00f3stico y tratamiento. Documento de consenso. Nefrolog\u00eda 2015; 35: 421-447. https:\/\/doi.org\/10.1016\/j.nefro.2015.07.005.","DOI":"10.1016\/j.nefro.2015.07.005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. NORIS M, CAPRIOLI J, BRESIN E, MOSSALI C, PIANETTI G, GAMBA S et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5: 1844-1859. https:\/\/doi.org\/10.2215\/CJN.02210310","DOI":"10.2215\/CJN.02210310"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. PEREIRA-VICTORIO CJ, V\u00c1ZQUEZ-MOLINERO A, LIZ\u00c1N-GARC\u00cdA M, LUIS J, GONZ\u00c1LEZ B. S\u00edndrome de HELLP en atenci\u00f3n primaria. Med Gen y Fam 2016; 5: 83-90. http:\/\/dx.doi.org\/10.1016\/j.mgyf.2016.02.002","DOI":"10.1016\/j.mgyf.2016.02.002"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"FAKHOURI","year":"2010","unstructured":"6. FAKHOURI F, ROUMENINA L, PROVOT F, SALL\u00c9E M, CAILLARD S, COUZI L et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010; 21: 859-867.","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"https:\/\/doi.org\/10.1681\/ASN.2009070706.","DOI":"10.1681\/ASN.2009070706"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. NESTER C, BARBOUR T, RODRIGUEZ DE CORDOBA S, DRAGON-DUREY MA, FREMEAUX-BACCHI V, GOODSHIP T et al. Atypical aHUS: state of the art. Mol Immunol 2015; 67: 31-42. https:\/\/doi.org\/10.1016\/j.molimm.2015.03.246.","DOI":"10.1016\/j.molimm.2015.03.246"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. SHAH N, RUTHERFORD C, MATEVOSYAN K, SHEN YM, SARODE R. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol 2013; 163: 514-519. https:\/\/doi.org\/10.1111\/bjh.12569.","DOI":"10.1111\/bjh.12569"},{"key":"ref9","unstructured":"9. NORIS M, BRESIN E, MELE C, REMUZZI G, ADAM M, ARDINGER H et al. Genetic atypical hemolytic-uremic syndrome. En: GeneReviews. Seattle (WA): University of Washington, 2021."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. ROUMENINA L, FRIMAT M, MILLER E, PROVOT F, DRAGON-DUREY MA, BORDEREAU P et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012; 119: 4182-4191. https:\/\/doi.org\/10.1182\/blood-2011-10-383281.","DOI":"10.1182\/blood-2011-10-383281"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. MARTINEZ-BARRICARTE R, MEIKE HEURICH, L\u00d3PEZ-PERROTE A, TORTAJADA A, PINTO S, L\u00d3PEZ-TRASCASA M et al. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome. Mol Immunol 2015; 66: 263-273. https:\/\/doi.org\/10.1016\/j.molimm.2015.03.248.","DOI":"10.1016\/j.molimm.2015.03.248"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. BRESIN E, RURALI E, CAPRIOLI J, SANCHEZ-CORRAL P, FREMEAUX-BACCHI V, RODRIGUEZ DE CORDOBA S et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 2013; 24: 475-486. https:\/\/doi.org\/10.1681\/ASN.2012090884.","DOI":"10.1681\/ASN.2012090884"},{"key":"ref13","unstructured":"13. Agencia Europea del Medicamento. Soliris (eculizumab). Ficha t\u00e9cnica. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/soliris-epar-product-information_es.pdfa 2012."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. FAKHOURI F, FILA M, HUMMEL A, RIBES D, SELLIER-LECLERC A, VILLE S et al. Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study. Blood 2021; 137: 2438-2449. http:\/\/doi.org\/10.1182\/blood.2020009280","DOI":"10.1182\/blood.2020009280"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/94650\/69626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:14:38Z","timestamp":1748844878000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/94650\/69626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,8,30]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.1006","relation":{},"ISSN":["2340-3527"],"issn-type":[{"type":"electronic","value":"2340-3527"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"e1006"}}